Cargando…
Changes in drug load during lacosamide combination therapy: A noninterventional, observational study in German and Austrian clinical practice
INTRODUCTION: Effects of antiepileptic drug (AED) load changes in patients with focal seizures have not been well evaluated. METHODS: SP1065 (NCT01673282) was a noninterventional, prospective, observational study conducted in a clinical practice setting. Patients (aged ≥18 years) with focal seizures...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698692/ https://www.ncbi.nlm.nih.gov/pubmed/31440722 http://dx.doi.org/10.1002/epi4.12346 |
_version_ | 1783444595918503936 |
---|---|
author | Reinhardt, Fritjof Weber, Yvonne G. Mayer, Thomas Luef, Gerhard Joeres, Lars Tennigkeit, Frank Dedeken, Peter De Backer, Marc Hellot, Scarlett Lauterbach, Thomas Webers, Tanja Arnold, Stephan |
author_facet | Reinhardt, Fritjof Weber, Yvonne G. Mayer, Thomas Luef, Gerhard Joeres, Lars Tennigkeit, Frank Dedeken, Peter De Backer, Marc Hellot, Scarlett Lauterbach, Thomas Webers, Tanja Arnold, Stephan |
author_sort | Reinhardt, Fritjof |
collection | PubMed |
description | INTRODUCTION: Effects of antiepileptic drug (AED) load changes in patients with focal seizures have not been well evaluated. METHODS: SP1065 (NCT01673282) was a noninterventional, prospective, observational study conducted in a clinical practice setting. Patients (aged ≥18 years) with focal seizures were enrolled within 7 days of being prescribed adjunctive lacosamide. Observation period was ~6 months. Drug load was assessed using percentage change in ratio of actual prescribed dose and World Health Organization defined daily dose (DDD) for concomitant AEDs and all AEDs (including lacosamide). Subgroups were defined for patients with at least one concomitant sodium channel–blocking AED (SCB [+]) and those without (SCB [−]). RESULTS: A total of 311 patients were assessed for safety, 302 for measurement of drug load, and 240 for effectiveness. Ratio of AED dose to DDD decreased for concomitant AEDs (−9.6%) and increased for all AEDs (including lacosamide; 15.5%). Median reduction in focal seizure frequency per 28 days was 100% (range: −100, 2275.8). 70.4% and 61.7% of patients had a ≥50% or ≥75% reduction in seizure frequency, respectively; 50.8% became seizure‐free. In the SCB (+) subgroup (n = 149), ratio of AED dose to DDD decreased for concomitant AEDs (−15.0%) and increased for all AEDs (10.7%). In the SCB (−) subgroup (n = 153), ratio of AED dose to DDD decreased for concomitant AEDs (−4.4%) and increased for all AEDs (20.2%). Fifty‐seven patients (18.3%) reported ADRs, most commonly dose >400 mg/d (7.1%). Seventeen patients (5.5%) had ADRs leading to discontinuation. SIGNIFICANCE: Addition of lacosamide resulted in reduction of concomitant AED drug load regardless of whether concomitant AEDs were SCB (+) or SCB (−). These results indicate that addition of lacosamide in patients with focal seizures could allow clinicians to withdraw or reduce the dose of less well‐tolerated or less effective AEDs. |
format | Online Article Text |
id | pubmed-6698692 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-66986922019-08-22 Changes in drug load during lacosamide combination therapy: A noninterventional, observational study in German and Austrian clinical practice Reinhardt, Fritjof Weber, Yvonne G. Mayer, Thomas Luef, Gerhard Joeres, Lars Tennigkeit, Frank Dedeken, Peter De Backer, Marc Hellot, Scarlett Lauterbach, Thomas Webers, Tanja Arnold, Stephan Epilepsia Open Full‐length Original Research INTRODUCTION: Effects of antiepileptic drug (AED) load changes in patients with focal seizures have not been well evaluated. METHODS: SP1065 (NCT01673282) was a noninterventional, prospective, observational study conducted in a clinical practice setting. Patients (aged ≥18 years) with focal seizures were enrolled within 7 days of being prescribed adjunctive lacosamide. Observation period was ~6 months. Drug load was assessed using percentage change in ratio of actual prescribed dose and World Health Organization defined daily dose (DDD) for concomitant AEDs and all AEDs (including lacosamide). Subgroups were defined for patients with at least one concomitant sodium channel–blocking AED (SCB [+]) and those without (SCB [−]). RESULTS: A total of 311 patients were assessed for safety, 302 for measurement of drug load, and 240 for effectiveness. Ratio of AED dose to DDD decreased for concomitant AEDs (−9.6%) and increased for all AEDs (including lacosamide; 15.5%). Median reduction in focal seizure frequency per 28 days was 100% (range: −100, 2275.8). 70.4% and 61.7% of patients had a ≥50% or ≥75% reduction in seizure frequency, respectively; 50.8% became seizure‐free. In the SCB (+) subgroup (n = 149), ratio of AED dose to DDD decreased for concomitant AEDs (−15.0%) and increased for all AEDs (10.7%). In the SCB (−) subgroup (n = 153), ratio of AED dose to DDD decreased for concomitant AEDs (−4.4%) and increased for all AEDs (20.2%). Fifty‐seven patients (18.3%) reported ADRs, most commonly dose >400 mg/d (7.1%). Seventeen patients (5.5%) had ADRs leading to discontinuation. SIGNIFICANCE: Addition of lacosamide resulted in reduction of concomitant AED drug load regardless of whether concomitant AEDs were SCB (+) or SCB (−). These results indicate that addition of lacosamide in patients with focal seizures could allow clinicians to withdraw or reduce the dose of less well‐tolerated or less effective AEDs. John Wiley and Sons Inc. 2019-06-22 /pmc/articles/PMC6698692/ /pubmed/31440722 http://dx.doi.org/10.1002/epi4.12346 Text en © 2019 UCB Pharma, S.A. Epilepsia Open published by Wiley Periodicals Inc. on behalf of International League Against Epilepsy. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Full‐length Original Research Reinhardt, Fritjof Weber, Yvonne G. Mayer, Thomas Luef, Gerhard Joeres, Lars Tennigkeit, Frank Dedeken, Peter De Backer, Marc Hellot, Scarlett Lauterbach, Thomas Webers, Tanja Arnold, Stephan Changes in drug load during lacosamide combination therapy: A noninterventional, observational study in German and Austrian clinical practice |
title | Changes in drug load during lacosamide combination therapy: A noninterventional, observational study in German and Austrian clinical practice |
title_full | Changes in drug load during lacosamide combination therapy: A noninterventional, observational study in German and Austrian clinical practice |
title_fullStr | Changes in drug load during lacosamide combination therapy: A noninterventional, observational study in German and Austrian clinical practice |
title_full_unstemmed | Changes in drug load during lacosamide combination therapy: A noninterventional, observational study in German and Austrian clinical practice |
title_short | Changes in drug load during lacosamide combination therapy: A noninterventional, observational study in German and Austrian clinical practice |
title_sort | changes in drug load during lacosamide combination therapy: a noninterventional, observational study in german and austrian clinical practice |
topic | Full‐length Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698692/ https://www.ncbi.nlm.nih.gov/pubmed/31440722 http://dx.doi.org/10.1002/epi4.12346 |
work_keys_str_mv | AT reinhardtfritjof changesindrugloadduringlacosamidecombinationtherapyanoninterventionalobservationalstudyingermanandaustrianclinicalpractice AT weberyvonneg changesindrugloadduringlacosamidecombinationtherapyanoninterventionalobservationalstudyingermanandaustrianclinicalpractice AT mayerthomas changesindrugloadduringlacosamidecombinationtherapyanoninterventionalobservationalstudyingermanandaustrianclinicalpractice AT luefgerhard changesindrugloadduringlacosamidecombinationtherapyanoninterventionalobservationalstudyingermanandaustrianclinicalpractice AT joereslars changesindrugloadduringlacosamidecombinationtherapyanoninterventionalobservationalstudyingermanandaustrianclinicalpractice AT tennigkeitfrank changesindrugloadduringlacosamidecombinationtherapyanoninterventionalobservationalstudyingermanandaustrianclinicalpractice AT dedekenpeter changesindrugloadduringlacosamidecombinationtherapyanoninterventionalobservationalstudyingermanandaustrianclinicalpractice AT debackermarc changesindrugloadduringlacosamidecombinationtherapyanoninterventionalobservationalstudyingermanandaustrianclinicalpractice AT hellotscarlett changesindrugloadduringlacosamidecombinationtherapyanoninterventionalobservationalstudyingermanandaustrianclinicalpractice AT lauterbachthomas changesindrugloadduringlacosamidecombinationtherapyanoninterventionalobservationalstudyingermanandaustrianclinicalpractice AT weberstanja changesindrugloadduringlacosamidecombinationtherapyanoninterventionalobservationalstudyingermanandaustrianclinicalpractice AT arnoldstephan changesindrugloadduringlacosamidecombinationtherapyanoninterventionalobservationalstudyingermanandaustrianclinicalpractice |